Multidrug-resistant tuberculosis treatment outcomes in Karakalpakstan, Uzbekistan: treatment complexity and XDR-TB among treatment failures
about
Association between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-AnalysisTreatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysisTreatment of tuberculosis in a region with high drug resistance: outcomes, drug resistance amplification and re-infectionCharacteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experienceAmbulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, IndiaOutcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalenceAdverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, IndiaMultidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patientsRisk factors associated with default from multi- and extensively drug-resistant tuberculosis treatment, Uzbekistan: a retrospective cohort analysisPublic health advocacy for the Berlin Declaration on tuberculosis in the former Soviet Union: The view of Médecins Sans FrontièresFactors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide StudyRelapse, re-infection and mixed infections in tuberculosis disease.What have we learned? A review of the literature on children's health and the environment in the Aral Sea area.Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis.Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis.Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment.Mycobacterium tuberculosis Beijing lineage favors the spread of multidrug-resistant tuberculosis in the Republic of Georgia.Relatively low primary drug resistant tuberculosis in southwestern EthiopiaThr202Ala in thyA is a marker for the Latin American Mediterranean lineage of the Mycobacterium tuberculosis complex rather than para-aminosalicylic acid resistance.Delay in the diagnosis and treatment of pulmonary tuberculosis in Uzbekistan: a cross-sectional study.Chest radiograph findings and time to culture conversion in patients with multidrug-resistant tuberculosis and HIV in Tugela Ferry, South Africa.Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomesRisk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.Where there is hope: a qualitative study examining patients' adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, UzbekistanThe burden of adverse events during treatment of drug-resistant tuberculosis in NamibiaOutcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002-2005.Characteristics and treatment outcomes of patients with multi-drug resistant tuberculosis at a tertiary care hospital in Peshawar, Pakistan.Multidrug- and extensively drug-resistant tuberculosis, Germany.A systematic review of the effectiveness of hospital- and ambulatory-based management of multidrug-resistant tuberculosis.Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.Extensively drug-resistant tuberculosis: new strains, new challenges.Treatment outcomes for multidrug-resistant tuberculosis under DOTS-Plus: a systematic review and meta-analysis of published studies.Totally drug-resistant tuberculosis and adjunct therapies.Efficacy and effect of free treatment on multidrug-resistant tuberculosis.Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients.Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.Community-based management versus traditional hospitalization in treatment of drug-resistant tuberculosis: a systematic review and meta-analysis.Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis.
P2860
Q27013703-9F432022-CFA7-44FD-8D44-07635B04FD41Q28476110-D067BD04-CB33-4084-A878-4E5874D80F7AQ28476640-EC6FDD5F-944E-404A-9683-6867F19AAD25Q28478005-2AC46F4B-3B2A-4110-A2C3-34D7C134D914Q28478204-B51F6DDF-2FB9-4145-8DB6-04DAA57733E7Q28479241-572BA8FD-1339-4B17-AC5D-F017E967D57EQ28481249-00459AA9-1445-4106-A766-51206A0843ACQ28482730-3E152266-9C24-46F9-94C9-C2C3C9F42CE2Q28534902-48126D9A-A9DC-40AC-95B5-D10060A2F7BBQ28535194-155956E8-19B8-483A-8D0F-78169B6A37E1Q28548334-6545BCFF-1EBD-40D1-AB48-7EFAC24CB18BQ30235139-A0F48B54-E593-4137-AAF6-D84B84B693CEQ30396338-67107EDC-51F7-487F-95CC-EEF4D36DA422Q30840887-F57336EB-83E0-4523-92D2-88753F68D16AQ33561777-C0E9A385-991D-497D-A429-0CDD7ACE2521Q34065647-F73C34FC-6FE2-43F5-BFD3-6F16A062CA70Q34190370-7695E564-A9F7-4851-9608-0DFC03BAD9DCQ34265158-826539D1-3371-4962-BF4E-1833AE7A829DQ34290168-0E9634F2-64A6-4DF2-A09E-96BB696D93ABQ34591235-25EEB096-F54D-48AA-B7B3-56C4F86B1800Q34989566-D6CB193D-2576-4DCD-96E3-02DDC16B8ABDQ35805940-3BF67F44-2B12-4F3A-BE27-BC1BD9C2E217Q35825931-E553244E-F322-4C5C-A8DC-2FD825B4EA9CQ36088019-FF0AB462-FF29-4AEB-A364-F30FA4C0C8FEQ36317060-57E93531-C423-459C-9377-1920D157779EQ36420040-396ECB63-A761-4B37-999C-DA161C1C7508Q36448646-7CC3BB82-78FD-49FE-A8DE-31B0B0A24726Q37072346-541EE882-7491-4449-B0B1-57A959AD7D0EQ37089599-712AF36A-3F05-4CEC-8AF6-6D248D72FC79Q37274766-E6D7D72A-1D66-448A-BE71-BC74649329FBQ37291363-094EE449-99A2-4C9B-B66F-E79FF3099C5DQ37589430-431E7589-71D7-4154-837C-90BFD04A9316Q38210265-BC8E8B47-D594-40C4-B9C3-6394A42BA3DAQ38718198-32754D9E-65C6-42CC-9EAB-43EB15323FA6Q42368090-201623DC-89D0-4B49-97E1-5F5235AFAC2DQ52594133-F6100FC7-C1E5-4B72-8292-C0B505381F6FQ53041364-EB5E4992-89B0-4686-814B-A09D06CD046EQ55208580-0DDBCC0B-B569-481E-9B8A-3B1F1A9654AF
P2860
Multidrug-resistant tuberculosis treatment outcomes in Karakalpakstan, Uzbekistan: treatment complexity and XDR-TB among treatment failures
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Multidrug-resistant tuberculos ...... DR-TB among treatment failures
@ast
Multidrug-resistant tuberculos ...... DR-TB among treatment failures
@en
Multidrug-resistant tuberculos ...... DR-TB among treatment failures
@nl
type
label
Multidrug-resistant tuberculos ...... DR-TB among treatment failures
@ast
Multidrug-resistant tuberculos ...... DR-TB among treatment failures
@en
Multidrug-resistant tuberculos ...... DR-TB among treatment failures
@nl
prefLabel
Multidrug-resistant tuberculos ...... DR-TB among treatment failures
@ast
Multidrug-resistant tuberculos ...... DR-TB among treatment failures
@en
Multidrug-resistant tuberculos ...... DR-TB among treatment failures
@nl
P2093
P2860
P3181
P1433
P1476
Multidrug-resistant tuberculos ...... DR-TB among treatment failures
@en
P2093
Clair Mills
Hamraev A Karimovich
Sholpan Allamuratova
Stobdan Kalon
Vinciane Sizaire
Yared Kebede
Zinaida N Tigay
P2860
P3181
P356
10.1371/JOURNAL.PONE.0001126
P407
P577
2007-11-07T00:00:00Z